BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Corindus Partners With Houston Methodist DeBakey Heart & Vascular Center to Launch Premier Robotic Training Site for Physicians

  Houston Methodist DeBakey Heart & Vascular Center has launched the first vascular robotic program in the Houston area with the installation of two CorPath® GRX Systems.

  December 1, 2017

   · 

  6 min read
• Novocure Receives Reimbursement Approval for Optune in Japan for the Treatment of Newly Diagnosed Glioblastoma

  Optune is a noninvasive, portable device approved in Japan to treat newly diagnosed and recurrent GBM.

  December 1, 2017

   · 

  7 min read
• Business

  Stellar Biotechnologies Reports Fiscal Year 2017 Financial Results

  During fiscal year 2017, the company advanced a number of strategic initiatives to optimize its manufacturing operations and to secure additional locations for the biologic source of KLH.

  December 1, 2017

   · 

  14 min read
• Business

  BlueRock Therapeutics Announces Appointment of Derek Hei, Ph.D. as Senior VP, Manufacturing, Quality and Regulatory

  Dr. Hei brings to BlueRock over twenty years of experience developing breakthrough cell and gene therapies from research through clinical trials.

  December 1, 2017

   · 

  2 min read
• Business

  Daiichi Sankyo and Translational Sciences Conclude Agreement, After Successful Phase 1a Trial, as Part of Daiichi Sankyo Portfolio Prioritization

  Daiichi Sankyo will return all rights to develop and commercialize Translational Sciences’ investigational thrombus dissolving agent, TS23, after a successful Phase 1a clinical trial.

  December 1, 2017

   · 

  2 min read
• Biotech Beach

  Impact Biomedicines Closes First Tranche of Oberland Capital Financing Following FDA Meeting

  Impact Biomedicines announced that it has achieved the first milestone in the Company’s previously disclosed $90 million financing with Oberland Capital, triggering the closing on the first tranche of $20 million.

  December 1, 2017

   · 

  4 min read
• Policy

  Life Sciences Ontario Launches Blueprint for Coordinated Ontario Life Sciences Strategy

  The document is endorsed by leading provincial and national life sciences, health, and economic organizations.

  December 1, 2017

   · 

  2 min read
• BioCapital

  Inova Personalized Health Accelerator Accepts HeMemics Biotechnologies Into Portfolio

  IPHA has selected HeMemics Biotechnologies as its first portfolio company.

  December 1, 2017

   · 

  3 min read
• Business

  CIRCA Scientific and Premier Sign Group Purchasing Contract for the S-CATH Esophageal Temperature Monitoring System

  CIRCA Scientific, the leader in advanced esophageal temperature monitoring, announced today that it has been awarded a group purchasing contract with Premier, Inc.

  December 1, 2017

   · 

  1 min read
• Business

  sphingotec Announces Collaboration With Mayo Clinic for Evaluation and Use of Biomarkers to Improve Diagnosis of Certain Diseases, Including Kidney Disease, Breast Cancer, Sepsis, and Cardiovascular Disease

  Through this agreement, Mayo Clinic will evaluate the biomarkers penKid and three others for research and potential routine clinical use.

  December 1, 2017

   · 

  2 min read